[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355297-105":59,"doc-detail-355297-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mbd3-increased-expression-by-brd4-and-facilitated-castration-resistant-prostate-cancer-cell-proliferation-by-inhibiting-pten","MBD3 increased expression by BRD4 and facilitated castration-resistant prostate cancer cell proliferation by inhibiting PTEN","","Prostate cancer (PCa) is a common malignancy in men with increasing mortality. Androgen deprivation therapy (ADT) can delay progression, but patients eventually develop castration-resistant prostate cancer (CRPC), for which effective treatments remain limited and the mechanisms are not fully understood. This study identifies Methyl-CpG binding domain protein 3 (MBD3) as a driver of CRPC, using patient RNA-seq data, clinical CRPC samples, and functional assays in vivo and in vitro. MBD3 is upregulated in PCa and CRPC and promotes proliferation by epigenetically silencing PTEN, is transcriptionally regulated by BRD4, and sensitizes CRPC cells to BET inhibitors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mbd3-increased-expression-by-brd4-and-facilitated-castration-resistant-prostate-cancer-cell-proliferation-by-inhibiting-pten/355297/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mbd3-increased-expression-by-brd4-and-facilitated-castration-resistant-prostate-cancer-cell-proliferation-by-inhibiting-pten/355297.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study focus on?","Question",{"text":113,"@type":114},"The study addresses how castration-resistant prostate cancer (CRPC) develops after ADT and why effective treatment options are still limited. It targets the unclear mechanisms driving CRPC progression.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does MBD3 influence CRPC cell proliferation?",{"text":118,"@type":114},"Elevated MBD3 promotes CRPC cell proliferation by epigenetically silencing the tumor suppressor gene PTEN. The work links this mechanism to both public database findings and clinical samples.",{"name":120,"@type":111,"acceptedAnswer":121},"What role do BRD4 and BET inhibitors play in the proposed pathway?",{"text":122,"@type":114},"MBD3 expression is transcriptionally regulated by BRD4, and MBD3 knockdown enhances the sensitivity of CRPC cells to BET inhibitors such as JQ1. The findings support a BRD4-MBD3-PTEN axis as a potential therapeutic route.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355297,1790797336,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Pan etal. Discover Oncology (2026) 17:418 [https://doi.org/10.1007/s12672-026-04628-7](https://doi.org/10.1007/s12672-026-04628-7)  \nDiscover Oncology  \nRESEARCH Open Access  \nMBD3 increased expression by BRD4 and facilitated castration-resistant prostate cancer cell proliferation by inhibiting PTEN  \nLiangming Pan1†, Jianliang Shen1†, Zhi Li1, Guilin Xie1*, Cong Chen1* and Xi Chen2*  \n†Liangming Pan and Jianliang Shen have contributed equally and co-first authors.  \n*Correspondence:  \nGuilin Xie [18862155767@163.com](18862155767@163.com)[ ](18862155767@163.com)Cong Chen [cctlyy2025@163.com](cctlyy2025@163.com)  \nXi Chen [15132767126@163.com](15132767126@163.com)[ ](15132767126@163.com)1Department of Urology, Tinglin Hospital of Jinshan District, 80 North Siping Road,  \nShanghai 201505, China 2Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China  \nAbstract  \nProstate cancer (PCa) is the most prevalent malignancy among men with a rising mortality rate. Androgen deprivation therapy (ADT) effectively treats PCa. However, patients inevitably progress to castration-resistant prostate cancer (CRPC) . There are still no effect methods for treating CRPC. The underlying mechanisms driving CRPC remain unclear. Methyl-CpG binding domain protein 3 (MBD3), a key member of the methyl-CpG binding protein family, exhibits high expression in lots of cancers. Here, we tried to find the mechanism of MBD3 in causing CRPC. We collected RNA-sequence data of PCa patients from public databases and collected CRPC samples from Tongji Hospital. Then, the expression of MBD3 in PCa samples was detected. By overexpression or knockdown MBD3, the role of MBD3 in affecting PCa cells proliferation was detected in vivo and vitro. Using public databases data, PCR, western blot and ChIP-qPCR experiments, the mechanism of MBD3 leading to PCa was analyzed. This study revealed that MBD3 is upregulated in both PCa and CRPC samples from public databases and clinical samples. Elevated MBD3 expression promotes CRPC cell proliferation by epigenetically silencing the tumor suppressor gene phosphatase and tensin homolog (PTEN) . Furthermore, MBD3 is transcriptionally regulated by bromodomain-containing protein 4 (BRD4), and MBD3 knockdown enhances the sensitivity of CRPC cells to BET inhibitors. These findings suggest that the BRD4-MBD3-PTEN axis is a new pathway in CRPC, with MBD3 representing a potential therapeutic target, particularly in combination with BET inhibitors.  \nKeywords MBD3, PTEN, BRD4, Cell proliferation, CRPC  \n1 Introduction  \nProstate cancer (PCa) is the most prevalent malignancy among elderly men and the second leading cause of cancer-related deaths in Western countries [1]. In China, the incidence and mortality rates of PCa have risen sharply due to increased life expectancy and changing lifestyle habits [2]. Androgen deprivation therapy (ADT) is an effective treatment for delaying the progression of PCa [3]. However, after a period of ADT, patients inevitably relapse into castration-resistant prostate cancer (CRPC) stage [4]. Once in the  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, y","cbCaipK0c9zucrmp","https://ap.wps.com/l/cbCaipK0c9zucrmp","pdf",2794159,16,"English","# Abstract\n# Keywords\n# 1 Introduction","[{\"question\":\"What problem does the study focus on?\",\"answer\":\"The study addresses how castration-resistant prostate cancer (CRPC) develops after ADT and why effective treatment options are still limited. It targets the unclear mechanisms driving CRPC progression.\"},{\"question\":\"How does MBD3 influence CRPC cell proliferation?\",\"answer\":\"Elevated MBD3 promotes CRPC cell proliferation by epigenetically silencing the tumor suppressor gene PTEN. The work links this mechanism to both public database findings and clinical samples.\"},{\"question\":\"What role do BRD4 and BET inhibitors play in the proposed pathway?\",\"answer\":\"MBD3 expression is transcriptionally regulated by BRD4, and MBD3 knockdown enhances the sensitivity of CRPC cells to BET inhibitors such as JQ1. The findings support a BRD4-MBD3-PTEN axis as a potential therapeutic route.\"}]","MBD3 increased expression by BRD4 and facilitated castration-resistant prostate cancer cell proliferation by inhibiting PTEN | PDF",1790117476,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59d11ed01433f81d63535b091765f000.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1740bb59cc3fcffee0d6388884f4545.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3e822836ca0de729e375e27ccb1173b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abfad2d2666e3ec4ca0d015b853be265.webp",980,1306]